Trial Profile
Decurarization After Thoracic Anesthesia - A Prospective Multicenter Double-blind Randomized Trial Comparing Sugammadex vs Neostigmine Reversal After Thoracic Anesthesia
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 18 Jun 2021
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary) ; Atropine; Neostigmine; Rocuronium bromide
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- Acronyms DATA
- 12 Jun 2021 Status changed from recruiting to discontinued.
- 10 Sep 2017 Planned End Date changed from 1 Jul 2017 to 1 Jul 2018.
- 10 Sep 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2018.